Researchers of the Melnick Lab recently published a study identifying a key mutation that disrupts the B-cell natural selection process during immune response, leading to aggressive diffuse large B-cell lymphoma within the body.
With AI helping to diagnose patients earlier and enabling the rapid development of treatments, it is possible that in a few decades, we may no longer have the need for Breast Cancer Awareness Month.